Status:
ACTIVE_NOT_RECRUITING
Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines
Lead Sponsor:
University of Stirling
Conditions:
General Health
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
For both healthy adults and patients with cardiovascular disease (CVD), aerobic fitness (V̇O2max) is a stronger predictor of the risk of future chronic disease and premature death than other establish...
Detailed Description
For both healthy adults and patients with cardiovascular disease (CVD), aerobic fitness (V̇O2max) is a stronger predictor of the risk of future chronic disease and premature death than other establish...
Eligibility Criteria
Inclusion
- Male
- Age ≥ 18 y or \<40 y
- BMI \< 35 kg/m2
- otherwise healthy, untrained individuals
Exclusion
- Age \<18 y or \>40 y
- BMI \> 35 kg/m2
- classification of 'highly physically active' according to the International Physical Activity Questionnaire (IPAQ)
- answering 'yes' to one or more questions on a standard Physical Activity Readiness Questionnaire (PAR-Q)
- resting heart rate ≥100bpm, clinically significant hypertension (140/90 mmHg)
- a personal history of metabolic or cardiovascular disease
- Female participants because of unknown effects of the menstrual cycle on the levels of the measured myokines.
Key Trial Info
Start Date :
October 23 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06141512
Start Date
October 23 2023
End Date
June 1 2025
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Stirling
Stirling, United Kingdom, FK9 4LA